VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 117 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $12,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $32,135,000 | 11.34% |
| VR Adviser, LLC | 16,047,286 | $43,970,000 | 5.65% |
| COMMODORE CAPITAL LP | 5,123,509 | $14,038,000 | 3.70% |
| Ghost Tree Capital, LLC | 2,000,000 | $5,480,000 | 1.60% |
| EPIQ PARTNERS, LLC | 916,100 | $2,510,000 | 1.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 707,733 | $1,939,000 | 1.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,824,938 | $10,480,000 | 0.88% |
| HighVista Strategies LLC | 438,239 | $1,201,000 | 0.80% |
| Nicholas Investment Partners, LP | 2,786,354 | $7,635,000 | 0.56% |
| NEA Management Company, LLC | 16,302,596 | $44,669,000 | 0.53% |